Consistent with our cell viability assay, the depletion of SPIN1 resulted in a significant increase in sensitivity to Cisplatin and Olaparib, as demonstrated by the remarkable decrease in tumor growth rate, weight, and size (Figs. 5E–J and EV4D, E). Here, SPIN1 is linked to neoplasm.